News and Announcements
Viralytics (ASX:VLA) – Investor and Shareholder Presentation
- Published July 23, 2013 10:53AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Viralytics is an Australian Stock Exchange listed company developing a portfolio of Oncolytic viruses that have the potential not only to provide a more effective treatment of a range of cancers, but also a substantial improvement in patients quality of life. Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics’ headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia.
Viralytics lead product CAVATAK™ has now entered the global phase II stage of clinical trial development with recruitment ongoing for a Phase II trial, treating Late Stage Melanoma patients – the CALM study. Viralytics New Drug (IND) application was allowed by the USA FDA, enabling this trial to be commenced in the USA during 2011. The Phase II trial will investigate the effectiveness of intratumourally administered CAVATAK™ in the treatment of Late Stage Melanoma.
Download the latest Investor & Shareholder Presentation below.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
